Interaction of propafenone enantiomers with human alpha 1-acid glycoprotein. 1991

J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Czechoslovakia.

The interaction of propafenone enantiomers with human alpha 1-acid glycoprotein was studied using high-performance liquid chromatography. Each of the two optical antipodes interacted with one class of high-affinity binding sites characterized by Ka(R) = (6.18 +/- 0.93) x 10(5) M-1, n(R) = 1.34 +/- 0.09 for the (R)-isomer and Ka(S) = (8.93 +/- 1.82) x 10(5) M-1, n(S) = 0.99 +/- 0.08 for the (S)-isomer. Nonspecific binding to secondary low-affinity high-capacity binding site(s) was only slightly greater in the case of the (S)-enantiomer (n'k'(S) = (1.06 +/- 0.09) x 10(4) M-1) compared to the (R)-enantiomer (n'k'(R) = (6.87 +/- 0.72) x 10(3) M-1). It was concluded that both enantiomers interact with common single class of high-affinity binding sites on AAG (along with nonspecific binding) exhibiting only slight stereoselectivity for propafenone.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009961 Orosomucoid Acid Seromucoid,Seromucoid,Serum Sialomucin,alpha 1-Acid Glycoprotein,alpha 1-Acid Seromucoid,A(1)-Acid Seromucoid,Acid alpha 1-Glycoprotein,Alpha(1)-Acid Glycoprotein,alpha 1-Acid Glycoprotein (Acute Phase),alpha 1-Glycoprotein Acid,Acid alpha 1 Glycoprotein,Glycoprotein, alpha 1-Acid,Seromucoid, Acid,Seromucoid, alpha 1-Acid,Sialomucin, Serum,alpha 1 Acid Glycoprotein,alpha 1 Acid Seromucoid,alpha 1 Glycoprotein Acid
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
October 1994, Journal of pharmaceutical and biomedical analysis,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
August 1989, Biochemical pharmacology,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
August 1984, British journal of clinical pharmacology,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
January 1981, Acta biochimica Polonica,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
January 1992, Journal of pharmacobio-dynamics,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
January 1987, Farmakologiia i toksikologiia,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
December 2003, British journal of clinical pharmacology,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
January 1989, Progress in clinical and biological research,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
May 1995, Journal of chromatography. A,
J Oravcová, and W Lindner, and P Szalay, and L Bohácik, and T Trnovec
June 1987, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!